Frankfurt am Main, September 17, 2013 -- Moody's Investors Service today affirmed Rhoen-Klinikum AG's ("RK") Baa3 issuer and senior unsecured ratings. The outlook remains negative. The action follows an announcement that Fresenius SE & Co. KGaA (Ba1) has agreed to acquire majority of the assets of RK for EUR 3.07 billion.

Vollständigen Artikel bei Moodys lesen